[1] 孟宪萌,许斌,陈维.基于中医数据挖掘探讨桃红四物汤治疗结肠癌机制网络药理学研究[J].辽宁中医药大学学报,2022,24(5):120-126. [2] 张彦琼,李梢.网络药理学与中医药现代研究的若干进展[J].中国药理学与毒理学杂志,2015,29(6):883-892. [3] 王子怡,王鑫,张岱岩,等.中医药网络药理学:《指南》引领下的新时代发展[J].中国中药杂志,2022,47(1):7-17. [4] 杜海涛,王琳,丁洁,等.分子对接在中药开发的应用现状与挑战[J].中国中药杂志,2024,49(3):671-680. [5] PINZI L C,RASTELLI G.Molecular docking:shifting paradigms in drug discovery[J].Int J Mol Sci,2019,20(18):4331. [6] DONG D,XU Z J,ZHONG W,et al.Parallelization of molecular docking:a review[J].Curr Top Med Chem,2018,18(12):1015-1028. [7] 吴谦. 医宗金鉴[M].北京:人民卫生出版社,1980:13. [8] 刘立,段金廒,宿树兰,等.用于妇科血瘀证痛经的四物汤类方——桃红四物汤的研究进展[J].中国中药杂志,2015,40(5):814-821. [9] 聂欣,成颜芬,王琳,等.桃红四物汤化学成分、药理作用、临床应用的研究进展及质量标志物的预测分析[J].中国实验方剂学杂志,2020,26(4):226-234. [10] PAN L Y,PENG C,WANG L,et al.Network pharmacology and experimental validation-based approach to understand the effect and mechanism of Taohong Siwu Decoction against ischemic stroke[J].J Ethnopharmacol,2022,294:115339. [11] BARRER M,ELLISON N.Platelet function[J].Anesthesiology,1977,46(3):202-211. [12] ZUFFEREY A,FONTANA P,RENY J L,et al.Platelet proteomics[J].Mass Spectrom Rev,2012,31(2):331-351. [13] KHODADI E.Platelet function in cardiovascular disease:activation of molecules and activation by molecules[J].Cardiovasc Toxicol,2020,20(1):1-10. [14] SUN Y Y,WANG T,LV Y,et al.MALAT1 promotes platelet activity and thrombus formation through PI3k/Akt/GSK-3β signalling pathway[J].Stroke Vasc Neurol,2023,8(3):181-192. [15] 历佳. 桃红四物汤治疗心血瘀阻型稳定型冠心病的疗效分析[J].中国医药指南,2020,18(7):185-186. [16] WU C J,CHEN J T,YEN T L,et al.Neuroprotection by the traditional Chinese medicine,Tao-Hong-Si-wu-Tang,against middle cerebral artery occlusion-induced cerebral ischemia in rats[J].Evid Based Complement Alternat Med,2011,2011:803015. [17] 王佐梅,肖洪彬,李雪莹,等.桃红四物汤的药理作用研究进展[J].现代中医药,2021,41(2):22-28. [18] 韩岚,许钒,章小兵,等.桃红四物汤活血化瘀作用的实验研究[J].安徽中医学院学报,2007,26(1):36-38. [19] 金翔,时乐,汪珊珊,等.桃红四物汤不同提取部位对血虚血瘀模型大鼠微循环的影响[J].安徽医药,2010,14(4):387-389. [20] 王珊,刘慧敏.血小板活化的分子机制及中药活性成分抗血小板研究进展[J].现代医药卫生,2022,38(14):2423-2427. [21] 唐家杨,苏聪平,罗慧,等.血小板活化机制及调节血小板中药的研究进展[J].中华中医药杂志,2021,36(11):6620-6626. [22] TYAGI T,JAIN K,GU S X,et al.A guide to molecular and functional investigations of platelets to bridge basic and clinical sciences[J].Nat Cardiovasc Res,2022,1(3):223-237. [23] YE T,SHI H X,PHAN-THIEN N,et al.The key events of thrombus formation:platelet adhesion and aggregation[J].Biomech Model Mechanobiol,2020,19(3):943-955. [24] KOENEN R R,BINDER C J.Platelets and coagulation factors:established and novel roles in atherosclerosis and atherothrombosis[J].Atherosclerosis,2020,307:78-79. [25] XIONG Y Y,BATH P M.Antiplatelet therapy for transient ischemic attack and minor stroke[J].Stroke,2020,51(11):3472-3474. [26] KAMRAN H,JNEID H,KAYANI W T,et al.Oral antiplatelet therapy after acute coronary syndrome:a review[J].JAMA,2021,325(15):1545-1555. [27] LIU T H,CHEN W H,CHEN X D,et al.Network pharmacology identifies the mechanisms of action of TaohongSiwu Decoction against essential hypertension[J].Med Sci Monit,2020,26:e920682. [28] 赵士清,郭青,叶超,等.基于网络药理学和分子对接技术探讨桃红四物汤治疗膝骨关节炎的作用机制[J].中国医药指南,2023,9(5):1-6. [29] YEE D L,SUN C W,BERGERON A L,et al.Aggregometry detects platelet hyperreactivity in healthy individuals[J].Blood,2005,106(8):2723-2729. [30] CHEN R,SONG C,QIU J J,et al.Exploring the potential mechanism of Taohong Siwu Decoction in the treatment of avascular necrosis of the femoral head based on network pharmacology and molecular docking[J].Medicine (Baltimore),2023,102(50):e35312. [31] BABU S,JAYARAMAN S.An update on β-sitosterol:a potential herbal nutraceutical for diabetic management[J].Biomed Pharmacother,2020,131:110702. [32] 肖志彬,刘小雷,成日青,等.β-谷甾醇对阿司匹林致胃黏膜损伤副作用及其药理作用的影响[J].中国实验方剂学杂志,2016,22(1):148-152. [33] GOGOI D,PAL A,CHATTOPADHYAY P,et al.First report of plant-derived β-sitosterol with antithrombotic,in vivo anticoagulant,and Thrombus-preventing activities in a mouse model[J].J Nat Prod,2018,81(11):2521-2530. [34] FARNDALE R W.Collagen-induced platelet activation[J].Blood Cells Mol Dis,2006,36(2):162-165. [35] LIU Y,YIN H J,SHI D Z,et al.Chinese herb and formulas for promoting blood circulation and removing blood stasis and antiplatelet therapies[J].Evid Based Complement Alternat Med,2012,2012:184503. [36] DROUIN M,SAENZ J,CHIFFOLEAU E.C-type lectin-like receptors:head or tail in cell death immunity[J].Front Immunol,2020,11:251. [37] 李敏,李莉,全云云,等.基于网络药理学、分子对接及实验验证探讨黄柏治疗痛风的作用机制[J].天然产物研究与开发,2023,35(7):1235-1246. |